Page 82

Febrero 2017

art ículo de revisi ón with a reduced risk of diverticulitis. Clin Gastroenterol Hepatol 2013; 11: 1631-5. 58. Kruis W, Meier E, Schumacher M, Mickisch O, Greinwald R, Mueller R, et al. Randomised clinical trial: mesalazina (Salofalk granulate) for uncomplicated diverticular disease of the colon–a placebo controlled study. Aliment Pharmacol Ther 2013; 37: 680-90. 59. Parente F, Bargiggia S, Prada A, Bortoli A, Giacosa A, Germanà B, et al. Intermittent treatment with mesalazine 218 in the prevention of diverticulitis recurrence: a randomized multicentre pilot double-blind placebo-controlled study of 24-month duration. Int J Colorectal Dis 2013; 28: 1423-31. 60. Tursi A, Di Mario F, Brabdimarte G, Elisei W, Picchio M, Loperfido S, et al. Intermittent versus every day mesalazine therapy in preventing complications of diverticular disease: a long-term follow-up study. Eur Rev Med Pharmacol Sci 2013; 17: 3244-8. 61. Tursi A, Brandimarte G, Elisei W, Giorgetti GM, Inchingolo CD, Aiello F. Faecal calprotectin in colonic diverticular disease: a case-control study. Int J Colorectal Dis 2009; 24: 49-55. 62. Raskin JB, Kamm MA, Jamal MM, Márquez J, Melzer E, Schoen RE, et al. Mesalamine does not prevent recurrent diverticulitis in phase 3 controlled trials. Gastroenterology 2014; 147: 793-802. 63. Imperiali G, Meucci G, Alvisi C, Fasoli R, Ferrara A, Girelli CM, et al. Segmental colitis associated with diverticula: a prospective study. Gruppo Di Studio Per Le Malatti e Inflammatorie Intestinali (GSMII). Am J Gastroenterol 2000; 95: 1014-6. 64. Stollman N, Magowan S, Shanahan F, Quigley E, DIVA Investigator Group. A randomized controlled study of Mesalamine after acute diverticulitis: results of the DIVA trial. J Clin Gastroenterol 2013; 47: 621-9. 65. Tursi A, Brandimarte G, Elisei W, Picchio M, Forti G, Pianese G, et al. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticula disease –a double-blind, randomised, placebo-controlled study. Aliment Pharmacol Ther 2013; 38: 741-51. 66. Bianchi M, Festa V, Moretti A, Ciaco A, Mangone M, Tomatore V, et al. Meta-analysis: long-therm therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment Pharmacol Ther 2011; 33: 902-10. 67. Lanas A, Ponce J, Bignamini A, Mearin F. One year intermittent rifaximin plus fibre supplementation vs fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study. Dig Liver Dis Enfermedad diverticular - D. Fluxá et al 2013; 45: 104-9. 68. Tursi A, Brandimarte G, Daffina R. Long-therm treatment with mesalazine and rifaximin vs. rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis 2002; 34: 510-5. 69. Chabok A, Pahlman L, Hjern F, Haajaniemi S, Smedh K, AVOD Study Group. Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg 2012; 99: 532-9. 70. Isacson D, Thorisson A, Andreasson K, Nikberg M, Smedh K. Outpatient, non-antiniotic management in acute uncomplicated diverticulitis: a prospective study. Int. Colorectal Dis 2015; 30: 1229-34. 71. Rafferty J, Shellito P, Hyman NH, Buie WD. Standards Committee of American Society of Colon and Rectal Surgeons. Practice parameters for sigmoid diverticulitis. Dis Colon Rectum 2006; 49: 939-44. 72. Bargellini T, Martellucci J, Tonelli P, Valeri A. Longterm results of treatment of acute diverticulitis: still lessons to be learned? Updates Surg 2013; 65: 125-30. 73. Andeweg CS, Berg R, Staal JB, Ten Broek RP, van Goor H. Patient-reported outcomes after conservative or surgical management of recurrence and chronic complaints of diverticulitis: Systematic review and meta-analysis. Clin. Gastroenterol Hepatol 2016; 14: 183-90. 74. Regenbogen SE, Hardiman KM, Hendren S, Morris Am. Surgery for diverticulitis in the 21 st century: a systematic review. JAMA Surg 2014; 149: 292-303. 75. Brar MS, Roxin G, Yaffe PB, Stranger J, Mac Lean AR, Buie WD. Colonoscopy following nonoperative management of uncomplicated diverticulitis may not be warranted. Dis. Colon Rectum 2013; 56: 1259-64. 76. Ou G, Rosenfeld G, Brown J, Chan N, Hong T, Lim H, et al. Colonoscopy after CT-diagnosed acute diverticulits: Is it really necessary? Can J Surg 2015; 58: 226-31. 77. Lahat A, Yahai H, Sakhnini E, Menachem Y, Bar-Meir S. Role of colonoscopy in patients with persistent acute diverticulitis. World J Gastroenterol 2008;14: 2763-6. 78. Lahat A, Yanai H, Menachem Y, Avidam B, Bar-Meir S. The feasibility and risk of early colonoscopy in acutediverticulitis: a prospective controlled study. Endoscopy 2007; 39: 521-4. 79. Tursi A, Brandimarte G, Di Mario F, Andreoli A, Annunziata ML, Astergiano M, et al. Development and validation of an Endoscopic Classification of Diverticular Disease of the Colon: The DICA Classification. Dig Dis 2015; 33: 68-76. 80. Tursi A. Prucalopride for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon. J Clin Gastroenterol 2016 Epub ahead of print. Rev Med Chile 2017; 145: 209-218


Febrero 2017
To see the actual publication please follow the link above